Clinical trial
Microburst VNS Therapy Feasibility Study in Subjects With Refractory Epilepsy
NCT03446664 is registered in ClinicalTrials.gov with LivaNova as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Microburst VNS Therapy Feasibility Study in Subjects With Refractory Epilepsy
- Lead sponsor
- LivaNova
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 27, 2018
- Completion date
- October 27, 2021
- Enrollment
- 33 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.